Skip to main content
. 2021 Dec 1;37:100916. doi: 10.1016/j.ijcha.2021.100916

Table 1.

Meta-analysis: summary of results.

Effect size
Heterogeneity
Outcome Studies (n) Patients (n) OR 95% CI P-value I2 (%) P-value
30-day outcomes (cumulative events at within 30 days after the procedure)
Mortality 5 872 0.81 0.18–3.63 0.780 0 0.466
MI 5 872 1.02 0.33–3.21 0.967 0 0.814
TVR 3 497 2.28 0.37–14.16 0.375 0 0.820
Stroke 5 872 1.30 0.17–9.87 0.802 0 0.446
MACCE 3 497 1.22 0.41–3.63 0.721 0 0.681



Outcomes at latest follow-up (cumulative events at > 1 year follow-up after the procedure)
Mortality 7 27,041 0.84 0.64–1.10 0.203 0 0.669
MI 7 1,149 0.40 0.20–0.80 0.010 0 0.519
TVR 6 27,041 0.49 0.37–0.64 <0.001 26 0.228
Stroke 5 949 1.20 0.49–2.93 0.694 0 0.476
MACCE 6 1,149 0.46 0.20–1.05 0.061 67 0.010

CI, confidence interval; MACCE, major adverse cardiac and cerebrovascular accidents; MI, myocardial infarction; OR, odds ratio; TVR, target vessel revascularization.